On this page
Sitagliptin
Active ingredient 7 prescription 13 with labelling
Overview
Source: NDC DirectoryIngredient name
SITAGLIPTIN
Base moiety
SITAGLIPTIN
RxNorm CUI
UNII
QFP0P1DV7Z
Medication products
11
Brand names
6
Dosage forms
6
FAERS reports
94,405 · not a risk measure
- BRYNOVIN Sitagliptin Hydrochloride Oral · Solution
- Sitagliptin Powder
- Sitagliptin Base Powder
- Sitagliptin Hydrochloride Powder
- Sitagliptin Malate Poultice
- Sitagliptin Tablet
- sitagliptin and metformin hydrochloride Tablet, Film Coated, Extended Release
- Sitagliptin and Metformin Hydrochloride Tablet, Film Coated
- ZITUVIMET Sitagliptin and Metformin Hydrochloride · Tablet, Film Coated
- ZITUVIMET XR sitagliptin and metformin hydrochloride · Tablet, Film Coated, Extended Release
- ZITUVIO Sitagliptin · Tablet
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 3 | Sitagliptin, Sitagliptin Base, Sitagliptin Hydrochloride |
| Tablet | 2 | Sitagliptin, ZITUVIO |
| TABLET, Film COATED, Extended Release | 2 | sitagliptin and metformin hydrochloride, ZITUVIMET XR |
| TABLET, Film Coated | 2 | Sitagliptin and Metformin Hydrochloride, ZITUVIMET |
| Solution | 1 | BRYNOVIN |
| Poultice | 1 | Sitagliptin Malate |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |